name: ZINC OXIDE 25 kg in 100 kg TOPICAL CREAM [Organic Matters SPF 50 Sunscreen]


name: ZINC OXIDE 68 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTINOXATE 67 mg in 1 mL TOPICAL CREAM [FUTURIST SKIN TINT SERUM]


name: Medical Food Oral Suspension [Essential Care Jr Ready To Drink]


name: Milk Protein Oral Suspension [Orgain Kids Protein]


name: Milk Protein Oral Suspension [Orgain Organic Nutrition]


name: Pea Protein Oral Suspension [Orgain Kids Plant Protein]


name: Pea Protein Oral Suspension [Orgain Organic Nutrition]


name: ULTRA VIOLETTE SPF ON THE GLOW Duo Pack Kit KIT


name: OCTINOXATE 65 mg in 1 mL / HOMOSALATE 33 mg in 1 mL / OCTISALATE 45 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL LIQUID [GINZING SPF 40 ENERGY-BOOSTING TINTED MOISTURIZER BROAD SPECTRUM SPF 40 SHEER TINT RELEASE]


name: OCTINOXATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g / TITANIUM DIOXIDE 3.5 g in 100 g / ZINC OXIDE 3 g in 100 g TOPICAL CREAM [Intellishade Original SPF 45]


name: OCTOCRYLENE 9 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 6 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL STICK [Unseen Sunscreen Stick SPF 40]


name: ZINC OXIDE 120 mg in 1 mL TOPICAL EMULSION [RMS REFRESH EYE BRIGHTENER SPF 30 BROAD SPECTRUM SUNSCREEN ADORE]


name: TRIFOLIUM PRATENSE FLOWER 0.5 g in 100 mL / SOY ISOFLAVONES 1.2 g in 100 mL / BLACK COHOSH 0.5 g in 100 mL TOPICAL CREAM [Bealions Estrogen]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Skin Metal Green Stealth]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL SPRAY [Sunscreen SPF 30]


name: OCTINOXATE 5.5 g in 100 g / OCTISALATE 3.5 g in 100 g / TITANIUM DIOXIDE 4 g in 100 g / ZINC OXIDE 3 g in 100 g TOPICAL CREAM [Intellishade Matte SPF 45]


name: OCTINOXATE 7.5 g in 100 g / OCTISALATE 4 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 3 g in 100 g TOPICAL CREAM [Intellishade Clear SPF 50]


name: TITANIUM DIOXIDE 2.5 g in 100 g / ZINC OXIDE 15.2 g in 100 g TOPICAL CREAM [Intellishade TruPhysical Clear SPF 50]


name: TITANIUM DIOXIDE 4.4 g in 100 g / ZINC OXIDE 14.4 g in 100 g TOPICAL LOTION [Intellishade TruPhysical SPF 45]


name: ALUMINUM CHLOROHYDRATE 20 g in 100 g TOPICAL AEROSOL, SPRAY [Lume Clean Tangerine]


name: ALUMINUM SESQUICHLOROHYDRATE 2.46 g in 14 g TOPICAL STICK [Lume Deodorant with Clinical Strength Sweat Control, Soft Powder]


name: AVOBENZONE 0.028 g in 1 mL / OCTISALATE 0.049 g in 1 mL / HOMOSALATE 0.098 g in 1 mL / OCTOCRYLENE 0.095 g in 1 mL TOPICAL OIL [Poolside Not Your Babys Oil. SPF 30 sunscreen body oil.]


name: AVOBENZONE 0.03 g in 1 g / HOMOSALATE 0.15 g in 1 g / OCTISALATE 0.05 g in 1 g / OCTOCRYLENE 0.1 g in 1 g TOPICAL OIL [Poolside Glow Butter Screen SPF 30 Shimmer sunscreen Butter]


name: AVOBENZONE 0.03 g in 1 mL / HOMOSALATE 0.1 g in 1 mL / OCTOCRYLENE 0.06 g in 1 mL / OCTISALATE 0.05 g in 1 mL TOPICAL GEL [Poolside Sun Daze Body Illuminator SPF 30 shimmer sunscreen gel]


name: AVOBENZONE 0.03 g in 1 mL / OCTISALATE 0.05 g in 1 mL / OCTOCRYLENE 0.1 g in 1 mL / HOMOSALATE 0.15 g in 1 mL TOPICAL SPRAY [Sugargirl Set SPF 30 sunscreen shimmer sunscreen mist for the face]


name: AVOBENZONE 3 mg in 100 mg / HOMOSALATE 10 mg in 100 mg / OCTISALATE 5 mg in 100 mg / OCTOCRYLENE 10 mg in 100 mg TOPICAL OIL [PINK BEACH SUNSCREEN BODY BROAD SPECTRUM SPF 50]


name: AVOBENZONE 3 mg in 100 mg / HOMOSALATE 10 mg in 100 mg / OCTISALATE 5 mg in 100 mg / OCTOCRYLENE 10 mg in 100 mg TOPICAL OIL [SANTAL BLOOM SUNSCREEN BODY BROAD SPECTRUM SPF 50]


name: CENTELLA ASIATICA LEAF 0.006 mg in 30 mg TOPICAL LIQUID [JAYSUING Hyaluronic Acid Moisturizing Sunscreen]


name: HOMOSALATE 0.05 g in 1 mL / AVOBENZONE 0.03 g in 1 mL / OCTOCRYLENE 0.045 g in 1 mL / OCTISALATE 0.04 g in 1 mL TOPICAL GEL [Sugargirl sun gloss SPF15 tinted lip gloss Sunscreen Tropic Twist]


name: HOMOSALATE 0.1 g in 1 g / OCTINOXATE 0.05 g in 1 g / OCTISALATE 0.05 g in 1 g / OCTOCRYLENE 0.08 g in 1 g / AVOBENZONE 0.03 g in 1 g TOPICAL CREAM [Sugargirl Glowy SPF 30 Face Screen Sunlight Shimmer Sunscreen for the face]


name: HOMOSALATE 0.15 g in 1 mL / AVOBENZONE 0.03 g in 1 mL / OCTISALATE 0.05 g in 1 mL / OCTOCRYLENE 0.1 g in 1 mL TOPICAL SPRAY [Poolside Orange Creme SPF 30 Sunscreen oil mist]


name: HOMOSALATE 70 mg in 1 mL / OCTISALATE 45 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL CREAM [DRAMATICALLY DIFFERENT MOISTURIZING LTN BROAD SPECTRUM SPF35]


name: OCTINOXATE 0.05 g in 1 mL / OCTOCRYLENE 0.08 g in 1 mL / OCTISALATE 0.05 g in 1 mL / HOMOSALATE 0.1 g in 1 mL / AVOBENZONE 0.03 g in 1 mL TOPICAL LOTION [Poolside Bronze Service Instant bronzing lotion. SPF30]


name: OCTISALATE 0.04 g in 1 mL / OCTOCRYLENE 0.08 g in 1 mL / HOMOSALATE 0.1 g in 1 mL / OCTINOXATE 0.06 g in 1 mL / AVOBENZONE 0.03 g in 1 mL TOPICAL LOTION [Sugargirl Glowy face screen sunbeam shimmer sunscreen for the face SPF 30]


name: OCTISALATE 0.05 g in 1 g / AVOBENZONE 0.03 g in 1 g / HOMOSALATE 0.15 g in 1 g / OCTOCRYLENE 0.1 g in 1 g TOPICAL OIL [Poolside Butter SCREEN SPF 30 sunscreen Butter]


name: OCTISALATE 0.05 g in 1 mL / AVOBENZONE 0.03 g in 1 mL / HOMOSALATE 0.01 g in 1 mL / OCTOCRYLENE 0.08 g in 1 mL / OCTINOXATE 0.05 g in 1 mL TOPICAL GEL [Poolside Orange Creme SPF 30 SCENTED gel sunscreen]


name: OCTISALATE 0.05 g in 1 mL / HOMOSALATE 0.15 g in 1 mL / OCTOCRYLENE 0.1 g in 1 mL / AVOBENZONE 0.03 g in 1 mL TOPICAL SPRAY [Poolside Hot Head SPF 30 hair scalp sunscreen mist]


name: OCTOCRYLENE 0.1 g in 1 mL / OCTISALATE 0.05 g in 1 mL / HOMOSALATE 0.15 g in 1 mL / AVOBENZONE 0.03 g in 1 mL TOPICAL SPRAY [Poolside Tropic Touch SPF 30 Sunscreen Body spray.]


name: OCTOCRYLENE 3 g in 100 g / HOMOSALATE 5 g in 100 g / AVOBENZONE 2 g in 100 g / OCTISALATE 3 g in 100 g TOPICAL LIPSTICK [Reef safe lip balm 01]


name: OCTOCRYLENE 9.9 g in 23.5 g / HOMOSALATE 7.3 g in 23.5 g / OCTISALATE 4.9 g in 23.5 g / ZINC OXIDE 7.04 g in 23.5 g TOPICAL STICK [DEWYTREE URBAN SHADE INVISIBLE SMOOTHING PORE SUNSTIC SUNSTICK]


name: TITANIUM DIOXIDE 1.31 g in 100 mL / ZINC OXIDE 17.68 g in 100 mL TOPICAL LOTION [Mineral Mattescreen SPF 40 - Golden Hour]


name: ZINC OXIDE 0.21 g in 1 g / OCTINOXATE 0.07 g in 1 g TOPICAL LOTION [Poolside Soft Serve Mineral Milk SPF 30 face sunscreen drops]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Oiana Mineral Sunscreen Drops]


name: ALLANTOIN 0.5 g in 100 mL / OATMEAL 1 g in 100 mL CUTANEOUS CHEWABLE GEL [Kenkoderm Eczema Honey Soothing Body]


name: ALLANTOIN 0.5 g in 100 mL / OATMEAL 1 g in 100 mL CUTANEOUS CREAM


name: CENTELLA ASIATICA 0.015 mg in 15 mg TOPICAL CREAM [EELHOE Bio Sun Stick]


name: DESOXYCORTICOSTERONE PIVALATE 15 kg in 15 kg NOT APPLICABLE POWDER, FOR SUSPENSION


name: ZINC OXIDE 24.5 g in 100 mL TOPICAL LOTION [BeautyBarrier]


name: HOMOSALATE 135 mg in 1 g / OCTISALATE 45 mg in 1 g / OCTOCRYLENE 90 mg in 1 g TOPICAL CREAM [NIDA Invisible Fit Sunscreen]


name: HOMOSALATE 50 mg in 1 mL / OCTOCRYLENE 45 mg in 1 mL / OCTISALATE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LIQUID [Poolside Frostbite Sunscreen Coconut SPF 15 Scented Lip Gloss]


name: HOMOSALATE 50 mg in 1 mL / OCTOCRYLENE 45 mg in 1 mL / OCTISALATE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LIQUID [Poolside Frostbite Sunscreen Papaya SPF 15 Scented Lip Gloss]


name: HOMOSALATE 50 mg in 1 mL / OCTOCRYLENE 45 mg in 1 mL / OCTISALATE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LIQUID [Poolside Frostbite Sunscreen Watermelon SPF 15 Scented Lip Gloss]


name: HOMOSALATE 50 mg in 1 mL / OCTOCRYLENE 45 mg in 1 mL / OCTISALATE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL OIL [Poolside Golden Hour SPF 15 Sunscreen Lip]


name: AVOBENZONE 3 mg in 100 mg / OCTINOXATE 7.5 mg in 100 mg TOPICAL LIPSTICK


name: HOMOSALATE 0.05 g in 1 g / ETHYLHEXYL SALICYLATE 0.05 g in 1 g / BUTYL METHOXYDIBENZOYLMETHANE 0.03 g in 1 g TOPICAL LOTION [Les Coja Organic SPF 30]


name: HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTINOXATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL LIQUID [Sugargirl Glowy SPF 30 Face Screen Daybreak Shimmer Sunscreen For the Face]


name: HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTINOXATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL LIQUID [Sugargirl Glowy SPF 30 Face Screen Solar Shimmer Sunscreen For the Face]


name: HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTINOXATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL LIQUID [Sugargirl Glowy SPF 30 Face Screen Sunlight Shimmer Sunscreen For the Face]


name: HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 90 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTINOXATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL LOTION [Poolside Sun Silk Body Sunglow 05 Fragrance SPF 30 Sunscreen Body]


name: HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTINOXATE 60 mg in 1 mL / OCTISALATE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LIQUID [Sugargirl Glowy Face Screen Sunbeam Shimmer Sunscreen For the Face SPF 30]


name: HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTINOXATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LIQUID [Poolside Orange Creme SPF 30 Scented Sunscreen]


name: ZINC OXIDE 10.08 g in 100 mL / TITANIUM DIOXIDE 5.616 g in 100 mL TOPICAL LOTION [ACCOJE PROTECTIVE AIR-FIT MINERAL SUNSCREEN]


name: ZINC OXIDE 151.8 mg in 1 g / TITANIUM DIOXIDE 98.4 mg in 1 g TOPICAL POWDER [Sugargirl Set Screen SPF 30 Setting Powder Sunscreen Light]


name: ZINC OXIDE 151.8 mg in 1 g / TITANIUM DIOXIDE 98.4 mg in 1 g TOPICAL POWDER [Sugargirl Set Screen SPF 30 Setting Sunscreen Medium]


name: ZINC OXIDE 151.8 mg in 1 g / TITANIUM DIOXIDE 98.4 mg in 1 g TOPICAL POWDER [Sugargirl Set Screen SPF 30 Setting Sunscreen Translucent]


name: ZINC OXIDE 20.3 g in 100 mL / TITANIUM DIOXIDE 10 g in 100 mL TOPICAL LOTION [CURESHIELD MANICURE SUNSCREEN]


name: OZONE 1 kg in 100 kg TOPICAL LIQUID [Plant Ozone Oil]


name: ALUMINUM SESQUICHLOROHYDRATE 15.2 g in 100 g TOPICAL SPRAY [Degree]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 40 mg in 1 g / OCTISALATE 40 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL LOTION [Intense Moisture Day Cream]


name: AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / HOMOSALATE 7 g in 100 mL / OCTISALATE 4.5 g in 100 mL TOPICAL CREAM [StriVectin TL Advanced Tightening Neck and Chest Broad Spectrum SPF 35 Sunscreen]


name: ZINC OXIDE 20.80 g in 100 g TOPICAL CREAM [Skin Perfecting CC Broad Spectrum Sunscreen SPF 48]


name: ZINC OXIDE 24 g in 100 mL TOPICAL SPRAY [Bella s Friends SPF50 Sunscreen]


name: Pyrilamine Maleate 1 g in 1 g NOT APPLICABLE POWDER


name: OCTOCRYLENE 1 g / HOMOSALATE 1 g / TITANIUM DIOXIDE 1 g / AVOBENZONE 1 g / ENSULIZOLE 1 g CUTANEOUS CREAM


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 50 mg in 1 mL TOPICAL LOTION [Welmedix HomeCare PRO Fragile Skin Dual Mineral Sunscreen]


name: ZINC OXIDE 14.69 g in 100 g TOPICAL STICK [SPF 50 Mineral Sunscreen Kids]


name: AVOBENZONE 1.5 g in 50 g / OCTINOXATE 3.5 g in 50 g / OCTOCRYLENE 5 g in 50 g / HOMOSALATE 5 g in 50 g / OCTISALATE 2.5 g in 50 g TOPICAL LOTION [LEBELAGE UV SUN ULTRA SHIELD SUN SCREENLOTION 50g]


name: OCTINOXATE 4.43 g in 59 mL / OXYBENZONE 2.95 g in 59 mL / AVOBENZONE 2.95 g in 59 mL TOPICAL LOTION [Mario Badescu The Moisture Magnet SPF 15]


name: OCTISALATE 50 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OXYBENZONE 50 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL SPRAY [Moisturizing Antioxidant SPF 50]


name: OCTOCRYLENE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / ZINC OXIDE 50 mg in 1 mL TOPICAL SPRAY [Hybrid SPF SPF 30]


name: Online Mendelian Inheritance in Man, 2026_02_05


name: FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 2


name: SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 6


name: NEURODEVELOPMENTAL DISORDER WITH GROWTH IMPAIRMENT, QUADRIPARESIS, AND POOR SPEECH


name: NEURODEVELOPMENTAL DISORDER WITH GROWTH IMPAIRMENT, QUADRIPARESIS, AND ABSENT SPEECH


name: RFC1, (AGGGC)n AND (AAGGC)n REPEAT EXPANSION


name: ABCD3, (CCG)n REPEAT EXPANSION, 5-PRIME UTR


name: ITGAV, 4-BP DEL, 1564AGTA (dbSNP SCV004171104)


name: HTRA1, -512G-A, PROMOTER (dbSNP rs11200638)


name: OSBPL2, 10-BP DEL, NT1443+1, 3-PRIME UTR


name: SNAPIN, IVS1, -1, G-A (dbSNP SCV006305058)


name: ARHGAP19, GLN151LYS (dbSNP rs1842859321)


name: APC, -195A-C AND 1-BP DEL, -125A, PROMOTER


name: ELFN1, 8-BP DEL, NT42 (dbSNP SCV001548241)


name: Polyneuropathy (sensory or sensorimotor)


name: Splenic rupture (spontaneous and intraoperative)


name: Diffuse leptomeningeal enhancement (MRI)


name: Hyperinsulinemic hypoglycemia (usually transient)


name: Granular osmiophilic material of variable electron density adjacent to basal membrane of vascular smooth muscle cell


name: Hyperintense lesions on T2-weighted MRI in the frontal and anterior temporal lobes


name: Hyperintense lesions in periventricular areas, the external capsule, basal ganglia, thalamus, and brainstem


name: Lacunar infarcts (develop after age 40 years)


name: Lesions in the internal capsule (after age 40 years)


name: Microbleeds (most smaller than 5 mm, after age 40 years)


name: Hyperintensities, lacunar infarcts, and microbleeds


name: Luminal narrowing or obliteration of small and medium-sized leptomeningeal arteries and long perforating arteries of the brain


name: Vasculopathy of the small arteries penetrating the white matter and of long perforating arteries in the brain


name: Luminal narrowing or obliteration of small and medium-sized leptomeningeal arteries


name: Electron-dense granular material close to vascular smooth muscle cell membranes


name: Well-defined erythematous border between affected and unaffected skin


name: Increased incidence of cancers (non-Hodgkin lymphoma, nonmelanoma skin cancer, and thyroid carcinoma)


name: Bilateral incomplete myelination anterior limb of interior capsule


name: Microdeletion of 8p23.1 includes 3.8Mb critical region


name: Elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST)


name: Deficiency of alpha-1,4-glucosidase (GAA)


name: Presence of vacuoles seen on muscle biopsy


name: Myopathy, progressive severe Cox-negative fibers seen on muscle biopsy


name: Lesions in the basal ganglia seen on MRI Enlarged subarachnoid spaces


name: Concentric visual field constriction, progressive


name: Retinoschisis, peripheral and/or central


name: Intraretinal pigmentation with nummular pattern


name: Reduced rod responses seen on electroretinogram (ERG)


name: Abnormal movements of extremities, face, and tongue


name: Increased factor VIII activity MOLECULAR BASIS Caused by mutation in the coagulation factor VIII gene (F8, 300814.0272)


name: Markedly elevated follicle-stimulating hormone (FSH)


name: Markedly elevated luteinizing hormone (LH)


name: Abnormal mitochondrial morphology seen on electron microscopy in skin, muscle, and nerve


name: Diffuse palmoplantar hyperkeratosis (affected areas include palm, soles, and dorsal surfaces of fingers (transgrediens))


name: Distinct margin between normal and affected skin


name: White spongy appearance upon exposure to water


name: Fibrillations and fasciculations seen on EMG


name: Axonal sensory neuropathy seen on nerve conduction velocity studies


name: Normal or increased subcutaneous truncal or abdominal adipose tissue


name: Normal or near-normal blue-yellow color vision


name: Reduced cone responses, severe, seen on ERG


name: Absent 30Hz flicker responses seen on ERG


name: Muscle atrophy and fatty replacement seen on MRI


name: Normal or moderately increased serum creatine kinase


name: Few responses to stimulation seen on ERG


name: Impaired production of type I and type III interferons


name: Seropositivity to viruses without severe illness


name: Normal T-cell adaptive responses to viral infections


name: Normal B-cell adaptive responses to viral infections


name: Acute respiratory distress syndrome (associated with SARS-CoV-2, influenza A, RSV infections)


name: Elevated gamma-glutamyltransferase (GGT) levels


name: Hepatomegaly (severe or profound in children with tendency to normalize with age)


name: Focal macro- and/or micronodular steatosis


name: 'From inside-to-outside' pattern of fatty degeneration seen on muscle MRI or CT


name: Diffuse inflammatory infiltrates seen on skin biopsy


name: Normal or increased white blood cell count


name: Normal overall numbers of circulating lymphocytes


name: Disorganized corticomedullary architecture and atrophic medulla


name: Neutralizing autoantibodies to certain type I interferons


name: Inflammatory changes seen on lung biopsy


name: Seizures (myoclonic, tonic, tonic-clonic, atonic, absence, and focal)


name: Poor respiratory drive at birth requiring intubation


name: Diffuse parenchymal loss throughout cerebral hemispheres, progressive seen on MRI


name: Thick nuchal fold seen on prenatal ultrasound


name: Small volume of the posterior cranial fossa


name: Recurrent eyelid twitching (indicative of possible seizure activity)


name: Reduced volume of the caudate and putamen


name: White matter hyperintensities seen on brain imaging


name: Reduction of periventricular white matter seen on MRI


name: Elevated NT-proBNP (N-Terminal Pro-Brain Natriuretic Peptide)


name: Maternal serum contains IgG alloantibodies that react with paternal ITGB3 antigens on fetal platelets


name: Maternal serum contains an IgG antibody that reacts with paternal ITGA2B antigen on fetal platelets


name: Maternal serum contains an IgG antibody that reacts with paternal ITGA2 antigen on fetal platelets


name: Degenerative changes in the walls of small vessels and arterioles


name: Degeneration and loss of vascular smooth muscle cells


name: T2-weighted hyperintensities in cortical and subcortical brain regions


name: Increased urinary deaminated glutathione (dGSH)


name: Dilated perivascular spaces (dPVS) on brain imaging


name: Prominent involvement of the basal ganglia and thalamus


name: 'Honeycomb' appearance of the deep gray matter in the basal ganglia and thalamus


name: Small cerebral vessel walls show thickened media with abundant hyaline, fibrin, and PAS-positive and toluidine blue-positive deposits


name: Myopathic changes seen on electromyogram


name: Demyelinating polyneuropathy with secondary axonal damage seen on EMG


name: Tumor has monomorphic epithelial histology


name: Perilobar nephrogenic rests seen on biopsy


name: Progressive loss of brain parenchyma with a frontotemporal predominance seen on brain imaging


name: Muscle weakness (predominantly lower limbs, due to axonal neuropathy)


name: Developmental delay (predominantly motor)


name: Subsarcolemmal accumulation of vacuoles seen on electron microscopy


name: Ovoid-shaped vertebral bodies (in infancy)


name: Absent ossification of proximal femoral epiphyses


name: Small femoral epiphyses (in early childhood)


name: Large femoral epiphyses (in later childhood)


name: Markedly short femoral necks (in later childhood)


name: Absent mid-diaphyseal constriction of metacarpals


name: Interictal generalized polyspike epileptiform activity


name: Muscle atrophy, primarily of the lower limbs


name: Atrioventricular block (1st and 2nd degree)


name: Nonsustained supraventricular tachycardia (NSVT)


name: Membranoproliferative lupus nephritis with crescent formation


name: Diffuse endothelial and mesangial cell proliferation


name: Clumped pigment deposits in peripheral retina


name: Nummular pigment deposits in peripheral retina


name: Patchy atrophy of the peripheral retinal pigment epithelium


name: Relatively enhanced S-cone responses seen on ERG


name: Increased excretion of xanthine, hypoxanthine, sulfocysteine, and thiosulfate


name: Periventricular leukomalacia on brain imaging


name: Small frontal lobes with abnormal gyration seen on brain MRI


name: Double outlet right ventricle Bicuspid aortic valve


name: Below average birth length (up to -3.2SD)


name: Abnormal foliation of the cerebellar vermis


name: Brain small vessel disease of the small arterioles


name: T2-weighted white matter hyperintensities in the brainstem, subcortical regions, periventricular region, basal ganglia, and thalami


name: Atherosclerosis of distal small cerebral arterioles


name: Loss of medial smooth muscle cells and pericytes


name: Reticular hyperkeratosis of the epidermis


name: Infiltration of melanophages in the dermis


name: Polyhydramnios MOLECULAR BASIS Caused by mutation in the potassium channel, subfamily K, member 3 gene (KCNK3, 603220.0002)


name: Diffuse brain atrophy seen on brain imaging


name: Accumulation of CSF over the frontotemporal regions


name: Amnestic syndrome of the hippocampal type (ASHT)


name: Variably increased serum creatine kinase


name: Impaired intellectual development (IQ <70)


name: Abnormal unscheduled DNA synthesis (UDS)


name: Microcephaly, progressive, severe (down to -11.69 SD)


name: Cortical dysplasia seen on brain imaging


name: Low cellularity seen on bone marrow biopsy


name: Increased myelocytes and metamyelocytes seen on bone marrow biopsy


name: Decreased or low normal band neutrophils and segmented neutrophils


name: Partial or total obliteration of pulp chambers


name: Crescent-shaped pulp remnants in some teeth


name: Distal muscle weakness, primarily of the lower limbs


name: Rimmed vacuoles seen on skeletal muscle biopsy


name: Rare p62-positive intranuclear inclusions


name: Narrowing of medullary cavity of long bones


name: Anarthria White matter changes seen on MRI


name: Impaired neurodevelopment, severe to profound


name: Decremental responses seen on repetitive nerve stimulation


name: Impaired function of the presynaptic neuromuscular junction (NMJ)


name: Low compound muscle action potentials (CMAPs) seen on EMG


name: Reduced spontaneous miniature endplate potential (MEPP) frequency and amplitude at the NMJ


name: Decreased numbers of readily releasable quanta at the NMJ


name: Type 2 fiber atrophy seen on muscle biopsy


name: Gait abnormalities due to peripheral neuropathy


name: Axonal peripheral neuropathy, length-dependent, motor predominant


name: Normal nerve conduction velocities consistent with axonal neuropathy seen on electrophysiologic studies


name: Decreased nerve conduction velocities consistent with demyelinating neuropathy


name: Intellectual disability (secondary to stroke)


name: Enlarged lateral ventricles seen on brain imaging


name: Hypertrophic cardiomyopathy (seen on prenatal ultrasound)


name: Cardiac conduction defect (suggestive of Wolff-Parkinson-White syndrome)


name: Mitochondrial respiratory complex IV deficiency


name: Reduced compound sensory action potential amplitudes seen on nerve conduction studies


name: Mild chronic neurogenic changes of motor unit action potentials seen on needle electromyography METABOLIC FEATURES


name: Marked reduction in scalp hair follicle counts


name: Patchy loss of facial hair (eyebrows, eyelashes, mustache, beard)


name: Longitudinal grooving and cleavage of hair cuticle seen on electron microscopy


name: Irregular transverse sections and peeling of hair cuticle seen on electron microscopy


name: Absent eyebrows and eyelashes (with aging)


name: Generalized tonic-clonic seizures, afebrile


name: Multiple pterygia (axillary, antecubital, inguinal)


name: Neurologic sequelae from intracranial hemorrhage


name: SNOMED Clinical Terms, Spanish Language Edition, 2026_02_10


name: Healthcare Common Procedure Coding System, 2026


name: HCPCS Version of Current Procedural Terminology (CPT), 2026


name: Cohealyx collagen dermal matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Marigen pacto, per square centimeter (add-on, list separately in addition to primary procedure)


name: Innovamatrix fd, per square centimeter (add-on, list separately in addition to primary procedure)


name: Intermittent urinary catheter; straight tip, hydrophilic coating, each


name: Intermittent urinary catheter; coude (curved) tip, hydrophilic coating, each


name: Intermittent urinary catheter; hydrophilic coating, with insertion supplies


name: Neurostimulator, integrated (implantable), rechargeable with all implantable and external components including charging system


name: Prosthesis, total, dual mobility, first carpometacarpal joint (implantable)


name: Leadless electrode, transmitter, battery (all implantable), for sequential left ventricular pacing


name: Anchor/screw for bone fixation, absorbable, metallic (implantable)


name: Pressure monitoring system, compartmental intramuscular (implantable), continuous, including all components (e.g., introducer, sensor), excludes mobile (wireless) software application


name: Bronchoscopy, rigid or flexible, including fluoroscopic guidance when performed, with transbronchial needle aspiration biopsy(s), trachea, main stem and/or lobar bronchus(i), with computer-assisted image-guided naviagation


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention (list separately in addition to code for primary procedure)


name: Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with percutaneous transluminal coronary lithotripsy


name: Insertion of pleural-peritoneal shunt with intercostal pump chamber, including imaging, injection(s) of contrast with radiological supervision and interpretation, when performed


name: Water circulating motorized cold therapy device (e.g., iceman) including all system components (e.g. pads, console, disposable parts), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)


name: Electronic ambulatory infusion pump (e.g. sapphire pump), including all pump components, including disposable components , non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)


name: Echogenic nerve block needles (e.g. sonoplex, sonoblock, sonotap), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)


name: Perforated continuous infusion catheter set (e.g. infiltralong), including all components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)


name: Continuous anesthesia echogenic conduction catheter set (e.g. sonolong), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)


name: Linear peristaltic pain management infusion pump (e.g. cadd-solis ambulatory infusion pump), and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)


name: Rotary peristaltic infusion pump (e.g., reusable ambit pump) including all disposable system components, reusable non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)


name: Electronic cryo-pneumatic compression, pain management system (e.g. game ready grpro 2.1 system), including control unit, anatomically correct wrap(s), and other system component(s), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)


name: Combination wheeled walker with seat and transport chair, folding, adjustable or fixed height


name: Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest


name: Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest


name: Initial psychiatric collaborative care management, in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional, initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan, review by the psychiatric consultant with modifications of the plan if recommended, entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant, and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies (list separately in addition to the advanced primary care management code)


name: Subsequent psychiatric collaborative care management, in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment (list separately in addition to advanced primary care management code)


name: Care management services for behavioral health conditions, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales, behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes, facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation, and continuity of care with a designated member of the care team (list separately in addition to advanced primary care management code)


name: Intraoperative nerve(s) cryoablation for post-surgical pain relief (list separately in addition to code for primary service)


name: Behavioral counseling for diabetes prevention, online, 60 minutes


name: Intrauterine copper contraceptive (miudella)


name: Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla, to trochanter, includes all accessory pads, straps, and interface, custom fabricated


name: Addition to lower extremity prosthesis, manual/automated adjustable air, fluid, gel or equal socket insert for limb volume management, any materials


name: Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at distal to metacarpal joint, including flexible or non-flexible interface, molded to patient model, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692


name: Single prosthetic digit, mechanical, can include metacarpophalangeal (mcp), proximal interphalangeal (pip), and/or distal interphalangeal (dip) joint(s), with or without locking mechanism, can include flexion or extension assist, any material, attachment, initial issue or replacement


name: Prosthetic thumb, mechanical, can include metacarpophalangeal (mcp), interphalangeal (ip) joint(s), with or without locking mechanism, can include flexion or extension assist, any material, attachment, initial issue or replacement


name: Addition to single prosthetic digit or thumb, mechanical, attachment, multiaxial and/or internal/external rotation/abduction/adduction mechanism, with or without locking feature, any material


name: Passive prosthetic digit or thumb prosthesis not including hand restoration partial hand, full or partial, custom made, any material, initial or replacement, per single passive prosthetic digit or thumb


name: Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose


name: Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose


name: Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose


name: Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose


name: Documentation of medical reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, other medical reasons)


name: Patients who have bilateral absence of eyes any time during the patient's history through the end of the measurement period


name: Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented


name: Retinal exam finding without evidence of retinopathy in both eyes with severity level documented (in measurement year or in the prior year)


name: Patient on oral chemotherapy on or within 30 days before denominator eligible encounter


name: Patient on oral chemotherapy on or within 30 days after denominator eligible encounter


name: Patient on oral chemotherapy during the performance period


name: Time last known well to hospital arrival less than or equal to 3.5 hours (<= 210 minutes)


name: Significant ocular conditions that impact the visual outcome of surgery


name: Encounter corresponds to initial diagnosis of sleep apnea or first contact with sleep apnea diagnosed patient


name: Postpartum care visit before or at 12 weeks of giving birth


name: Patients with an active diagnosis of bipolar disorder any time prior to the end of the measure assessment period


name: Patients with an active diagnosis of personality disorder any time prior to the end of the measure assessment period


name: Patients with an active diagnosis of schizophrenia or psychotic disorder any time prior to the end of the measure assessment period


name: Patients who received hospice or palliative care service any time during denominator identification period or the measure assessment period


name: Patients with an active diagnosis of pervasive developmental disorder any time prior to the end of the measure assessment period


name: Patient ever had a diagnosis of dementia


name: Patients with a pre-operative visual acuity better than 20/40


name: Patient had a diagnosis of asthma with any contact during the current or prior performance period or had asthma present on an active problem list any time during the performance period


name: Patient was in hospice or receiving palliative care services at any time during the performance period


name: Diagnosis for chronic obstructive pulmonary disease, emphysema, cystic fibrosis, or acute respiratory failure


name: Patient diagnosis for chronic hepatitis c


name: Documentation of at least two attempts to follow up with patient within 180 days of treatment


name: No documentation of at least two attempts to follow up with patient within 180 days of treatment


name: Patient follow up more than 180 days after treatment


name: Patient had a lumbar fusion on the same date as the discectomy/laminectomy procedure


name: Patients with an existing diagnosis of lynch syndrome


name: Patient received recommended doses of hepatitis b vaccination based on age


name: Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period


name: Documentation of medical reason(s) for not administering hepatitis b vaccine (e.g., prior anaphylaxis due to the hepatitis b vaccine)


name: Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules


name: Patient did not receive recommended doses of hepatitis b vaccination based on age


name: Patients with diagnosis of huntington's disease


name: Patients with diagnosis of cognitive impairment or alzheimer's disease


name: Patients receiving hospice or palliative care or who died during the measurement period


name: Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period


name: Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period


name: Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis)


name: Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period


name: Patients admitted to a skilled nursing facility (snf) during the period of evaluation


name: Patients in hospice in the year before or during the period of evaluation


name: Patients with a diagnosis for dementia in the year before or during the period of evaluation


name: Receiving esrd mcp dialysis services by the provider during the performance period


name: Patients that reported a fall since the last visit


name: Patients that reported a fall occurred who had a plan of care for falls documented or patients that did not report a fall


name: Patients that had a fall who did not have a plan of care for falls documented or do not have documentation of being assessed for falls


name: Interventional radiology mips value pathway


name: Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion


name: Amchothick, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amnioplast 3, per square centimeter (add-on, list separately in addition to primary procedure)


name: Aeroguard, per square centimeter (add-on, list separately in addition to primary procedure)


name: Neoguard, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amchoplast excel, per square centimeter (add-on, list separately in addition to primary procedure)


name: Membrane wrap lite, per square centimeter (add-on, list separately in addition to primary procedure)


name: Duograft ac, per square centimeter (add-on, list separately in addition to primary procedure)


name: Duograft aa, per square centimeter (add-on, list separately in addition to primary procedure)


name: Trigraft ft, per square centimeter (add-on, list separately in addition to primary procedure)


name: Renew ft matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amniodefend ft matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Advograft one, per square centimeter (add-on, list separately in addition to primary procedure)


name: Advograft dual, per square centimeter (add-on, list separately in addition to primary procedure)


name: Axolotl graft ultra, per square centimeter (add-on, list separately in addition to primary procedure)


name: Axolotl dualgraft ultra, per square centimeter (add-on, list separately in addition to primary procedure)


name: Apollo ft, per square centimeter (add-on, list separately in addition to primary procedure)


name: Acesso trifaca, per square centimeter (add-on, list separately in addition to primary procedure)


name: Neothelium ft, per square centimeter (add-on, list separately in addition to primary procedure)


name: Neothelium 4l, per square centimeter (add-on, list separately in addition to primary procedure)


name: Neothelium 4l+, per square centimeter (add-on, list separately in addition to primary procedure)


name: Ascendion, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amnioplast double, per square centimeter (add-on, list separately in addition to primary procedure)


name: Grafix duo, per square centimeter (add-on, list separately in addition to primary procedure)


name: Surgraft ac, per square centimeter (add-on, list separately in addition to primary procedure)


name: Surgraft aca, per square centimeter (add-on, list separately in addition to primary procedure)


name: Acelagraft, per square centimeter (add-on, list separately in addition to primary procedure)


name: Natalin, per square centimeter (add-on, list separately in addition to primary procedure)


name: Summit aaa, per square centimeter (add-on, list separately in addition to primary procedure)


name: Summit ac, per square centimeter (add-on, list separately in addition to primary procedure)


name: Summit fx, per square centimeter (add-on, list separately in addition to primary procedure)


name: Polygon3 membrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Absolv3 membrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap 2.0, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap dual plus, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap hydro plus, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap fenestra plus, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap fenestra, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap tribus, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap hydro, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amniomatrixf3x, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amchomatrixdl, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amniomatrixf4x, per square centimeter (add-on, list separately in addition to primary procedure)


name: Choriofix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Cygnus solo, per square centimeter (add-on, list separately in addition to primary procedure)


name: Simplichor, per square centimeter (add-on, list separately in addition to primary procedure)


name: Alexiguard sl-t, per square centimeter (add-on, list separately in addition to primary procedure)


name: Alexiguard tl-t, per square centimeter (add-on, list separately in addition to primary procedure)


name: Alexiguard dl-t, per square centimeter (add-on, list separately in addition to primary procedure)


name: Nuform, per square centimeter (add-on, list separately in addition to primary procedure)


name: Pma skin substitute product, not otherwise specified (list in addition to primary procedure)


name: 510(k) skin substitute product, not otherwise specified (list in addition to primary procedure)


name: 361 hct/p skin substitute product, not otherwise specified (list in addition to primary procedure)


name: Infectious disease (wound infection), identification of 65 organisms and 30 antibiotic resistance genes, wound swab, real-time pcr, reported as positive or negative for each organism


name: Infectious disease (periprosthetic joint infection), analysis of 11 biomarkers (alpha defensins 1-3, creactive protein, microbial antigens for staphylococcus [spa, spb], enterococcus, candida, and c. acnes, total nucleated cell count, percent neutrophils, rbc count, and absorbance at 280 nm) using immunoassays, hematology, clinical chemistry, synovial fluid, and diagnostic algorithm reported as a probability score


name: Endocrinology (diabetes), insulin (ins) gene methylation using digital droplet pcr, insulin, and cpeptide immunoassay, serum, hemoglobin a1c immunoassay, whole blood, algorithm reported as diabetes-risk score


name: Drug assay, presumptive, 77 drugs or metabolites, urine, liquid chromatography with tandem mass spectrometry (lc-ms/ms), results reported as positive or negative


name: Allergy and immunology (chronic recurrent angioedema), 4 bradykinin peptides, liquid chromatography and tandem mass spectrometry (lc-ms/ ms), whole blood, quantitative


name: Allergy and immunology (hereditary alpha tryptasemia), dna, analysis of tpsab1 gene copy number variation using digital pcr, whole blood, results reported with genotypespecific interpretation of alpha-tryptase copy number and algorithmic classification as normal or abnormal


name: Hematology (red cell membrane disorders), rbcs, osmotic gradient ektacytometry, whole blood, quantitative


name: Reproductive medicine (endometrial microbiome assessment), real-time pcr analysis for 31 bacterial dna targets from endometrial biopsy, reported with quantified levels of bacterial presence and targeted treatment recommendations


name: Reproductive medicine (endometrial microbiome assessment), real-time pcr analysis for 10 bacterial dna targets from endometrial biopsy, reported with quantified levels of bacterial presence and targeted treatment recommendations


name: Oncology (prostate), immunoassay for total prostate-specific antigen (psa) and free psa, serum or plasma, combined with clinical features, algorithm reported as a probability score for clinically significant prostate cancer


name: Infectious disease (antimicrobial susceptibility), phenotypic antimicrobial susceptibility testing of positive blood culture using microfluidic sensor technology to quantify bacterial growth response to multiple antibiotic types, reporting categorical susceptibility (susceptible, susceptible dose dependent, intermediate, resistant), minimum inhibitory concentration, and interpretive comments


name: Oncology (liver), analysis of over 1,000 methylated regions, cell-free dna from plasma, algorithm reported as a quantitative result


name: Oncology (urothelial carcinoma), dna methylation and mutation analysis of 6 biomarkers (twist1, otx1, onecut2, fgfr3, hras, tert promoter region), methylation-specific pcr and targeted next-generation sequencing, urine, algorithm reported as a probability index for bladder cancer and upper tract urothelial carcinoma


name: Low Income Home Energy Assistance Program


name: Low Income Home Energy Assistance Program cooling assistance program


name: Low Income Home Energy Assistance Program crisis assistance program


name: Low Income Home Energy Assistance Program heating assistance program


name: Low Income Home Energy Assistance Program weatherization assistance program


name: Low Income Household Water Assistance Program


name: Non-emergency medical transportation program


name: Prescription medication assistance program


name: Senior Farmers' Market Nutrition Program


name: Special Supplemental Nutrition Program for Women, Infants and Children


name: State energy rate affordability assistance program


name: Temporary Assistance for Needy Families Program


name: Farmers' Market Nutrition Program for Women, Infants and Children


name: Federal Housing Administration Home Mortgage Program


name: United States Department of Agriculture Rural Mortgage Program


name: United States Department of Agriculture Rural Housing Repair Program


name: United States Department of Housing and Urban Development approved housing counseling agency


name: Federal Housing Administration approved lender


name: Community land trust home ownership program


name: Human leukocyte antigen A*33:03 detected


name: Human leukocyte antigen B*13:01 detected


name: Human leukocyte antigen B*38:02 detected


name: Human leukocyte antigen B*40:01 detected


name: Human leukocyte antigen B*59:01 detected


name: Human leukocyte antigen A*33:03 not detected


name: Human leukocyte antigen B*13:01 not detected


name: Human leukocyte antigen B*38:02 not detected


name: Human leukocyte antigen B*40:01 not detected


name: Human leukocyte antigen B*59:01 not detected


name: Vascular hyperintensity of precuneus on transverse relaxation time magnetic resonance imaging


name: Symmetrical vascular hyperintensity of periventricular white matter on fluid attenuated inversion recovery magnetic resonance imaging


name: Symmetrical vascular hyperintensity of caudate nucleus on fluid attenuated inversion recovery magnetic resonance imaging


name: Vascular hyperintensity of periventricular white matter on fluid attenuated inversion recovery magnetic resonance imaging


name: Symmetrical vascular hyperintensity of globus pallidus on fluid attenuated inversion recovery magnetic resonance imaging


name: Symmetrical vascular hyperintensity of putamen on fluid attenuated inversion recovery magnetic resonance imaging


name: Symmetrical vascular hyperintensity of thalamus on fluid attenuated inversion recovery magnetic resonance imaging


name: Symmetrical vascular hyperintensity of periventricular white matter on transverse relaxation time magnetic resonance imaging


name: Symmetrical vascular hyperintensity of caudate nucleus on transverse relaxation time magnetic resonance imaging


name: Symmetrical vascular hyperintensity of globus pallidus on transverse relaxation time magnetic resonance imaging


name: Symmetrical vascular hyperintensity of putamen on transverse relaxation time magnetic resonance imaging


name: Symmetrical vascular hyperintensity of thalamus on transverse relaxation time magnetic resonance imaging


name: Asymmetrical vascular hyperintensity of periventricular white matter on fluid attenuated inversion recovery magnetic resonance imaging


name: Confluent vascular hyperintensity of periventricular white matter on fluid attenuated inversion recovery magnetic resonance imaging


name: Focal vascular hyperintensity of periventricular white matter on fluid attenuated inversion recovery magnetic resonance imaging


name: Patchy vascular hyperintensity of periventricular white matter on fluid attenuated inversion recovery magnetic resonance imaging


name: Asymmetrical vascular hyperintensity of periventricular white matter on transverse relaxation time magnetic resonance imaging


name: Confluent vascular hyperintensity of thalamus on transverse relaxation time magnetic resonance imaging


name: Focal vascular hyperintensity of periventricular white matter on transverse relaxation time magnetic resonance imaging


name: Patchy vascular hyperintensity of periventricular white matter on transverse relaxation time magnetic resonance imaging


name: Confluent vascular hyperintensity of periventricular white matter on transverse relaxation time magnetic resonance imaging


name: SNOMEDCT_US_2026_03_01 to ICD10CM_2026 Mappings


name: SNOMEDCT_US_2026_03_01 to ICD10_2016 Mappings


name: Medical Expenditure Panel Survey (MEPS) Health Insurance (HX) Section


name: Guidance for percutaneous nephrolithotomy


name: Guidance for percutaneous embolization coil for repair of aneurysm


name: Guidance for repositioning pacemaker lead


name: Guidance for placement of magnetic seeds


name: Tau protein.phosphorylated 217/Amyloid beta 42 peptide


name: Hereditary paraganglioma-pheochromocytoma multigene analysis


name: Blood Volume.standard error of the regression/Blood Volume.calculated


name: Amputee correction factor/Ideal blood volume


name: Erythrocyte volume deviation/Ideal volume


name: Hematologic malignancy gene fusion panel


name: Background illumination color code sequence


name: Corrected localized deviation from normal


name: Local deviation probability normals flag


name: Global deviation probability normals flag


name: Corrected localized deviation from normal probability


name: Chromosomal aneuploidy likelihood analysis


name: Behavioral Risk Factor Surveillance System Adverse Childhood Experiences Module 2021


name: Abnormal Involuntary Movement Scale Original 14-Item Version


name: Lived environment annual mean of particulate matter concentration


name: Healthcare-medically underserved areas- census tract


name: Healthcare medically underserved areas county


name: Periodic personal health monitoring report


name: Number of colonoscopies or enteroscopies


name: Names or numbers of nurses & technicians


name: Compression percentage rate of the procedure by resident physician


name: Number of approaches to papilla until deep cannulation


name: Final approach method during deep cannulation


name: Number of confirmed days of complication


name: Macroscopic morphology classification of cancer and tumor


name: Macroscopic classification of early cancer


name: Pancreatobiliary cholangioscopic & pancreatoscopic biopsy or cytology


name: Pancreatobiliary endoscopy cholangioscopic & pancreatoscopic biopsy-cytology


name: Mycobacterium abscessus complex subspecies identification


name: The Home Energy Insecurity Scale Threshold Classification


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 & Respiratory syncytial virus Ag panel


name: How many times has this happened during your lifetime


name: Leukocyte deformability sepsis assessment


name: Major Experiences of Discrimination Abbreviated


name: Bacterial & Viral & Inflammation severity multigene mRNA expression panel


name: Sexually transmitted blood borne infections panel


name: Treponema pallidum Ab and Rubella Virus Ab.IgG panel


name: Hereditary idiopathic pulmonary fibrosis multigene analysis


name: Combined humoral and cell-mediated immunodeficiency multigene analysis


name: Inborn errors of immunity multigene analysis


name: Phagocytic cell disorder and chronic granulomatous disease multigene analysis


name: Adverse Childhood Experience Questionnaire for Adults


name: 16-item Transportation Security Index Category


name: 6-item Transportation Security Index Category


name: 3-item Transportation Security Index Category


name: DePaul Questionnaire - Post-Exertional Malaise (DSQ-PEM)


name: Children's HealthWatch Housing Stability Vital Sign Impression


name: Pediatric emergency department beds-admitted


name: Adult emergency department beds-admitted


name: Surge non-intensive care unit beds-inactive


name: Surge non-intensive care unit beds-active


name: Specialty neonatal intensive care unit-level 1


name: Specialty neonatal intensive care unit-level 2


name: Specialty neonatal intensive care unit-level 3


name: Specialty neonatal intensive care unit-level 3 plus beds


name: Specialty neonatal intensive care unit-level 4 beds


name: Specialty neonatal intensive care unit beds


name: Pediatric medicine telemetry and general acute care beds


name: Pediatric intensive care unit (level of care) beds


name: Adult medicine telemetry and general acute care beds


name: Adult intensive care unit (level of care) beds


name: Mycobacterium preliminary growth:PrThr:Pt:Plr fld:Ord:Organism specific culture


name: Mycobacterium preliminary growth:PrThr:Pt:CSF:Ord:Organism specific culture


name: Mycobacterium preliminary growth:PrThr:Pt:XXX:Ord:Organism specific culture


name: Mycobacterium preliminary growth:PrThr:Pt:BAL:Ord:Organism specific culture


name: Mycobacterium preliminary growth:PrThr:Pt:Bronchoalveolar aspirate:Ord:Organism specific culture


name: Respiratory syncytial virus RNA:PrThr:Pt:BAL:Ord:Non-probe.amp.tar


name: Human coronavirus 229E+HKU1+OC43 RNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Observation:Prid:Pt:Bronchoalveolar aspirate:Nom:Acid fast stain.Kinyoun modified


name: SARS coronavirus 2 lineage:Type:Pt:Nph:Nom:Sequencing


name: Pneumocystis jirovecii DNA:NCnc:Pt:Respiratory System Specimen:Qn:Probe.amp.tar


name: Influenza virus A & B RNA:Prid:Pt:Nph:Nom:Probe.amp.tar


name: Respiratory syncytial virus RNA:Prid:Pt:Nph:Nom:Probe.amp.tar


name: Tick-borne encephalitis virus RNA:PrThr:Pt:Urine:Ord:Probe.amp.tar


name: Epstein Barr virus DNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Hepatitis A virus RNA:PrThr:Pt:Bld:Ord:Probe.amp.tar


name: Pneumocystis jirovecii DNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Tick-borne encephalitis virus RNA:PrThr:Pt:Bld:Ord:Probe.amp.tar


name: Influenza virus A whole genome segment sequence:ID:Pt:XXX:Nom:Sequencing


name: Hepatitis B virus basal core promoter mutation:PrThr:Pt:Ser/Plas:Nom:Sequencing


name: Hepatitis B virus precore mutation:PrThr:Pt:Ser/Plas:Nom:Sequencing


name: Acinetobacter calcoaceticus-baumannii complex DNA:PrThr:Pt:Respiratory system specimen.lower:Ord:Non-probe.amp.tar


name: Hepatitis B virus surface Ag DNA mutations:PrThr:Pt:Ser/Plas:Ord:Sequencing


name: Tau protein.phosphorylated 217/Amyloid beta 42 peptide:Ratio:Pt:Ser/Plas:Qn


name: Borrelia burgdorferi Ab.IgM:PrThr:Pt:Ser:Ord:Line blot


name: Borrelia burgdorferi Ab.IgG:PrThr:Pt:Ser:Ord:Line blot


name: Hereditary paraganglioma-pheochromocytoma multigene analysis:MCnc:Pt:Bld/Tiss:Qn:Molgen


name: traMADol & Metabolites Panel:-:Pt:Ser/Plas:-:LC/MS/MS


name: Blood Volume.standard error of the regression/Blood Volume.calculated:RelRto:Pt:^Patient:Qn:Calculated


name: Hematocrit^^adjusted to ideal blood volume:VFr:Pt:^Patient:Qn:Calculated


name: Amputee correction factor/Ideal blood volume:RelRto:Pt:^Patient:Qn:Calculated


name: Body weight deviation/ideal weight:RelRto:Pt:^Patient:Qn:Calculated


name: Erythrocyte volume deviation/Ideal volume:RelRto:Pt:^Patient:Qn:Calculated


name: Plasma volume deviation/Ideal volume:RelRto:Pt:^Patient:Qn:Calculated


name: Blood volume deviation/Ideal volume:RelRto:Pt:^Patient:Qn:Calculated


name: Observation:PrThr:Pt:Bronchoalveolar aspirate:Ord:Acid fast stain.Ziehl-Neelsen


name: Respiratory syncytial virus RNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Parainfluenza virus RNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Middle East respiratory syndrome coronavirus RNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Human metapneumovirus RNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Mycoplasma pneumoniae DNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Legionella pneumophila DNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Chlamydophila pneumoniae DNA:PrThr:Pt:Bronchoalveolar aspirate:Ord:Non-probe.amp.tar


name: Streptococcus pyogenes DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Streptococcus pneumoniae DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Streptococcus agalactiae DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Staphylococcus aureus DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Pseudomonas aeruginosa DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Proteus sp DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Moraxella catarrhalis DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Enterobacter cloacae complex DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Acinetobacter calcoaceticus-baumannii complex DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Hematologic malignancy gene fusion panel:-:Pt:XXX:-:Molgen


name: Hepatocyte growth factor receptor Ag expression:Find:Pt:Tiss:Doc:IA


name: Melanoma-associated antigen 4 panel:-:Pt:Tiss:-:Immune stain


name: Borrelia burgdorferi Ab.IgG index:PrThr:Pt:Ser+CSF:Ord


name: Chromosomal aneuploidy likelihood analysis:Find:Pt:Plas.cfDNA:Doc:NIPS


name: Natriuretic peptide.B prohormone N-Terminal:MCnc:Pt:Ser/Plas/Bld:Qn:IA


name: SMN1 gene copy number:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: Escherichia coli O157:H7 Ag:PrThr:Pt:Stool:Ord:IA.rapid


name: Aspergillus fumigatus CYP51A gene DNA TR34 & TR46 resistance mutations:Prid:Pt:BAL:Nom:Probe.amp.tar


name: Glutamate decarboxylase 65 Ab:ACnc:Pt:Ser/Plas:Qn:IA


name: Glutamate decarboxylase 65 Ab:ACnc:Pt:CSF:Qn:IA


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag:Prid:Pt:Nose:Ord:IA.rapid


name: Sin a 1 (Mustard Brassica & Sinapis spp) Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Polistes dominulus venom Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Hom s lactoferrin Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Corylus avellana pollen Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Gallus domesticus egg yolk Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Gallus domesticus egg white Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Apis mellifera venom Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Vespula vulgaris venom Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Sus domesticus epithelial Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Solenopsis richteri & Solenopsis invicta venom Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Brassica & Sinapis spp Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Secale cereale pollen Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Ovis aries epithelial Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Meleagris gallopavo meat Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Lupinus albus seed Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: (Litopaenaeus setiferus+Farfantepenaeus aztecus+Farfantepenaeus dourarum) Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Equus caballus milk Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Capra hircus epithelial Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Canis familiaris urine Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Mycobacterium abscessus complex subspecies identification:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Respiratory syncytial virus Ag:PrThr:Pt:Nose:Ord:IA.rapid


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 & Respiratory syncytial virus Ag panel:-:Pt:Nose:-:IA.rapid


name: Leukocyte deformability sepsis assessment:Imp:Pt:Bld:OrdQn:Cytometry.microfluidic


name: Prostate cancer risk:Find:Pt:Tiss:Doc:AI Image analysis


name: Bacterial & Viral & Inflammation severity multigene mRNA expression panel:-:Pt:Bld:-


name: Sexually transmitted blood borne infections panel:-:Pt:Ser:-:IA


name: Treponema pallidum Ab and Rubella Virus Ab.IgG panel:-:Pt:Ser:-


name: Bacterial infection likelihood:Score:Pt:Bld:Qn:Calculated.mRNA expression


name: Viral infection likelihood:Score:Pt:Bld:Qn:Calculated.mRNA expression


name: Hereditary idiopathic pulmonary fibrosis multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Bone marrow failure multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Combined humoral and cell-mediated immunodeficiency multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Inborn errors of immunity multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Phagocytic cell disorder and chronic granulomatous disease multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Chlamydia trachomatis L1+L2+L3 DNA:PrThr:Pt:Skin:Ord:Probe.amp.tar


name: Mycoplasma sp:Prid:Pt:Prostatic fld:Nom:Organism specific culture


name: Borrelia burgdorferi 18kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Human papilloma virus 35 DNA:LnCnc:Pt:Plas.cfDNA:Qn:Probe.amp.tar


name: Human papilloma virus 31 DNA:LnCnc:Pt:Plas.cfDNA:Qn:Probe.amp.tar


name: Human papilloma virus 18 DNA:LnCnc:Pt:Plas.cfDNA:Qn:Probe.amp.tar


name: Human papilloma virus 33 DNA:LnCnc:Pt:Plas.cfDNA:Qn:Probe.amp.tar


name: Human papilloma virus 16 panel:-:Pt:Plas.cfDNA:-


name: Rubella virus RNA:PrThr:Pt:Amnio fld:Ord:Probe.amp.tar


name: Hepatitis B virus reverse transcriptase gene mutations:PrThr:Pt:Ser/Plas:Ord:Sequencing


name: Serratia marcescens DNA:NCncRange:Pt:Bronchoalveolar aspirate:SemiQn:Non-probe.amp.tar


name: Camelus dromedarius milk Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: Inflammatory illness severity:Score:Pt:Bld:Qn:Calculated.mRNA expression


name: Human papilloma virus 16 DNA:LnCnc:Pt:Plas.cfDNA:Qn:Probe.amp.tar


name: ETDRS 35 or higher and/ or macular edema


name: Structure or vehicle not meant for human habitation


name: Building with shared facilities not meant for human habitation


name: Outside/ Open Air (not part of an encampment)


name: Behavioral health facility (e.g., mental health, substance use)


name: Other correctional/detention facility (e.g., Border detention facility)


name: Shelter or safe haven (congregate setting)


name: Correctional/ detention facility of unknown or unspecified type


name: Group home or residential facility not provided by employer or school


name: Juvenile correctional/ detention facility


name: Medical respite/Recuperative care facility for unhoused individuals


name: Private residence in a long-term arrangement


name: Vehicle meant for human habitation (e.g., RV)


name: Temporary, non-congregate housing provided by charity or government program (e.g., transitional housing, hotel/motel)


name: Hotel/Motel or Vacation rental in a long term arrangement


name: Private residence in a short-term arrangement with subsequent housing


name: Private residence in a short-term arrangement without subsequent housing


name: Hotel/ motel/ vacation rental in a short term arrangement without subsequent housing


name: Vehicle meant for human habitation (e.g., RV) without long-term location or subsequent housing


name: Camping with subsequent housing (e.g., recreational camping)


name: Behavioral health treatment facility (e.g., mental health or substance use)


name: Behavioral health treatment facility (e.g., mental health or substance use) [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Correctional/detention facility of unknown or unspecified type [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Federal adult correctional facility [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Group home or residential facility not provided by employer or school [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Juvenile correctional/ detention facility [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Local adult jail/detention facility [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Long term care facility [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Other correctional/detention facility (e.g., Border detention facility) [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Other inpatient medical facility [stay <90 days and previously in shelter, safe haven or unsheltered]


name: State adult correctional facility [stay <90 days and previously in shelter, safe haven or unsheltered]


name: Commercial building (inside) (e.g., shop, mall, office building)


name: Correctional or Detention Facility, Unknown type


name: Covered area on exterior of a building (e.g., awning, doorway, or porch)


name: Disaster Shelter for people evacuated due to natural disaster or large scale incident


name: Living with family, friends, or roommate(s)


name: Medical respite for unhoused individuals


name: Other correctional or detention facility (not a federal prison, state prison, local jail, or juvenile detention facility - e.g., border detention facility)


name: Outside (e.g., cave, forest, woods, wilderness, field, ravine, gulch)


name: Outdoor covered space (e.g., picnic shelter)


name: Outdoor property or grounds or community center, library or other building


name: Outdoor property or grounds of a place of worship


name: Parking structure/Parking garage/ Parking deck


name: Recuperative care facility/center for unhoused individuals


name: Substance use Rehabilitation center/ clinic


name: Rented room in a private residence/ Renting a room


name: Sanctioned Encampment (known in some cities as Safe Outdoor Space, Transitional Community)


name: Staying with family, friends, or roommate(s)


name: Temple: Temple outdoor property or grounds


name: Unfinished building / Under construction


name: Unspecified type of Correctional or Detention Facility


name: Inpatient rehabilitation center (physical rehabilitation)


name: Inpatient rehabilitation center (substance use, behavioral health)


name: A few with stimulation (auditory swallow)


name: Spontaneous and intermittent <24h of age, spontaneous and frequent >24h of age


name: Repeated attempts to hold nipple in mouth stimulate to suck


name: Grasp breast tongue down lips flanged rhythmic sucking


name: ASA II (A patient with mild systemic disease)


name: ASA III (A patient with severe systemic disease)


name: ASA IV (A patient with severe systemic disease that is a constant threat to life)


name: ASA V (A moribund patient who is not expected to survive without the operation)


name: Drug Withdrawal from 6 days or more before


name: Drug Withdrawal from 8 days or more before


name: Positive - Not Complied with Helicobacter Pylori Eradication


name: Evaluation Post Colon Cancer Chemotherapy/Radiation Therapy


name: Postoperative Surveillance for Colon Cancer


name: Preoperative (Indian ink-injection) Marking


name: Endoscopic Treatment (Treatment Request from Another Hospital)


name: Obscure Gastrointestinal Bleeding Scrutiny


name: Bile Duct Abnormalities in Other Image Inspection


name: Bile Duct Stents Replacement/Decannulation


name: Accessory Pancreatic Duct EPBD (endoscopic papillary balloon dilation)


name: Accessory Pancreatic Duct EST (endoscopic sphincterotomy)


name: Bile Duct EPBD (endoscopic papillary balloon dilation)


name: Bile Duct EST (endoscopic sphincterotomy)


name: Pancreatic Duct EPBD (endoscopic papillary balloon dilation)


name: Pancreatic Duct EST (endoscopic sphincterotomy)


name: Cholecystography impossible <Stone Incarceration >


name: Up as far as Lower Part of Common Bile Duct


name: Up as far as Peripheral Intrahepatic Bile Duct


name: Up as far as Porta Hepatis Region Bile Duct


name: Unsucccess to Cannulation for Pancreatic Duct


name: No Measured Value (Unadministered endoscopic pancreatico-cholangiography)


name: Guide Wire for Pancreatic Duct + Pancreatic Duct Incision


name: Papillotomy Knife + Guide Wire + Contrast Agent


name: Unsucccess to Cannulation as far as Deep Part


name: [Head and Neck Invasion Depth] Deeper than Muscular Layer


name: [Head and Neck Invasion Depth] Intraepithelial Layer


name: [Head and Neck Invasion Depth] Other (Specify)


name: [Head and Neck Invasion Depth] Subepithelial Layer


name: [Head and Neck Macroscopic Classification] Other (Specify)


name: [Head and Neck Macroscopic Classification] Remnant Recurrence


name: [Head and Neck Macroscopic Classification] Type0-IIa (Slightly Elevated Type)


name: [Head and Neck Macroscopic Classification] Type0-IIb (Flat Type)


name: [Head and Neck Macroscopic Classification] Type0-IIc (Slightly Depressed Type)


name: [Head and Neck Macroscopic Classification] Type0-III (Superficial and Excavated Type)


name: [Head and Neck Macroscopic Classification] Type0-Ip (Pedunculated Type)


name: [Head and Neck Macroscopic Classification] Type0-Is (Sessile (Broad Based) Type)


name: [Head and Neck Macroscopic Classification] Type1 (Protruding Type)


name: [Head and Neck Macroscopic Classification] Type2 (Ulcerative and Localized Type)


name: [Head and Neck Macroscopic Classification] Type3 (Ulcerative and Infiltrative Type)


name: [Head and Neck Macroscopic Classification] Type4 (Diffusely Infiltrative Type)


name: [Head and Neck Macroscopic Classification] Type5 (Unclassified Type)


name: [Post Pharyngolaryngoesophagectomy] Gastric Tube Reconstruction


name: [Post Pharyngolaryngoesophagectomy] Jejunum Reconstruction


name: [Post-chemoradiotherapy] CR (Complete Response)


name: [Post-chemoradiotherapy] PD (Progressive Disease)


name: [Post-chemotherapy] CR (Complete Response)


name: [Post-radiotherapy] CR (Complete Response)


name: Other Organ Cancer Invade Laryngopharynx


name: Endoscopic Laryngo-pharyngeal Surgery <ELPS>


name: Hemostasis of Non-varicose Veins (including Prevention)


name: Tumor Ablation (including Argon Plasma Coagulation)


name: [Head and Neck Major Histological Diagnosis] Mild Dysplasia


name: [Head and Neck Major Histological Diagnosis] Moderate Dysplasia


name: [Head and Neck Major Histological Diagnosis] n.a.


name: [Head and Neck Major Histological Diagnosis] Other (Specify)


name: [Head and Neck Major Histological Diagnosis] Severe Dysplasia


name: [Head and Neck Pathological Invasion Depth] Deeper than Muscular Layer


name: [Head and Neck Pathological Invasion Depth] Intraepithelial Layer


name: [Head and Neck Pathological Invasion Depth] n.a.


name: [Head and Neck Pathological Invasion Depth] Subepithelial Layer


name: [Head and Neck Pathological Macroscopic Classification] n.a.


name: [Head and Neck Pathological Macroscopic Classification] Type0-IIa (Slightly Elevated Type)


name: [Head and Neck Pathological Macroscopic Classification] Type0-IIb (Flat Type)


name: [Head and Neck Pathological Macroscopic Classification] Type0-IIc (Slightly Depressed Type)


name: [Head and Neck Pathological Macroscopic Classification] Type0-III (Superficial and Excavated Type)


name: [Head and Neck Pathological Macroscopic Classification] Type0-Is (Sessile (Broad Based) Type)


name: Resection Specimen Diameter - Major Axis (mm) (Specify)


name: Resection Specimen Diameter - Minor Axis (mm) (Specify)


name: Tumor Diameter - Major Axis (mm) (Specify)


name: [Esophagus Invasion Depth] Other (Specify)


name: [Esophagus Macroscopic Classification] Other (Specify)


name: [Esophagus Macroscopic Classification] Remnant Recurrence


name: [Esophagus Macroscopic Classification] Type0-IIa (Slightly Elevated Type)


name: [Esophagus Macroscopic Classification] Type0-IIb (Flat Type)


name: [Esophagus Macroscopic Classification] Type0-IIc (Slightly Depressed Type)


name: [Esophagus Macroscopic Classification] Type0-III (Superficial and Excavated Type)


name: [Esophagus Macroscopic Classification] Type0-Ip (Pedunculated Type)


name: [Esophagus Macroscopic Classification] Type1 (Protruding Type)


name: [Esophagus Macroscopic Classification] Type2 (Ulcerative and Localized Type)


name: [Esophagus Macroscopic Classification] Type3 (Ulcerative and Infiltrative Type)


name: [Esophagus Macroscopic Classification] Type4 (Diffusely Infiltrative Type)


name: [Esophagus Macroscopic Classification] Type5 (Unclassified Type)


name: [Horizontal Location] 3/4 Circumferential - Sub circumferential


name: [Magnifying Endoscopy Findings] A (Magnifying Endoscopy Classification by JES)


name: [Magnifying Endoscopy Findings] AVA-large (Magnifying Endoscopy Classification by JES)


name: [Magnifying Endoscopy Findings] AVA-middle (Magnifying Endoscopy Classification by JES)


name: [Magnifying Endoscopy Findings] AVA-small (Magnifying Endoscopy Classification by JES)


name: [Magnifying Endoscopy Findings] B1 (Magnifying Endoscopy Classification by JES)


name: [Magnifying Endoscopy Findings] B2 (Magnifying Endoscopy Classification by JES)


name: [Magnifying Endoscopy Findings] B3 (Magnifying Endoscopy Classification by JES)


name: [Magnifying Endoscopy Findings] Other (Specify)


name: [Gastroesophageal Reflux Disease] Grade A


name: [Gastroesophageal Reflux Disease] Grade C


name: [Gastroesophageal Reflux Disease] Grade D


name: [Gastroesophageal Reflux Disease] Grade M


name: [Gastroesophageal Reflux Disease] Grade N


name: [Post Subtotal Esophagectomy] Colon Reconstruction


name: [Post Subtotal Esophagectomy] Gastric Tube Reconstruction


name: [Post Subtotal Esophagectomy] Jejunum Reconstruction


name: [Unstained Area of the Iodine Staining] Grade A (No Iodine Unstaining)


name: [Unstained Area of the Iodine Staining] Grade B (Other than A and C)


name: [Unstained Area of the Iodine Staining] Grade C


name: [Unstained Area of the Iodine Staining] Other (Specify)


name: Lightly Stained Area of the Iodine Staining


name: Endoscopic Injection Sclerotherapy <EIS>


name: Percutaneous Trans Esophageal Gastro-tubing <PTEG>


name: [Esophagus Major Histological Diagnosis] n.a.


name: [Esophagus Pathological Invasion Depth] Deeper than SM2


name: [Esophagus Pathological Invasion Depth] EP


name: [Esophagus Pathological Invasion Depth] MM


name: [Esophagus Pathological Invasion Depth] n.a.


name: [Esophagus Pathological Invasion Depth] SM1


name: [Esophagus Pathological Macroscopic Classification] n.a.


name: [Esophagus Pathological Macroscopic Classification] Type0-IIa (Slightly Elevated Type)


name: [Esophagus Pathological Macroscopic Classification] Type0-IIb (Flat Type)


name: [Esophagus Pathological Macroscopic Classification] Type0-IIc (Slightly Depressed Type)


name: [Esophagus Pathological Macroscopic Classification] Type0-III (Superficial and Excavated Type)


name: [Esophagus Pathological Macroscopic Classification] Type0-Ip (Pedunculated Type)


name: [Esophagus Pathological Macroscopic Classification] Type0-Is (Sessile (Broad Based) Type)


name: [Stomach Macroscopic Classification] Excavated


name: [Stomach Macroscopic Classification] Protruded (Protruding)


name: [Stomach Macroscopic Classification] Type0-IIa (Slightly Elevated Type)


name: [Stomach Macroscopic Classification] Type0-IIb (Flat Type)


name: [Stomach Macroscopic Classification] Type0-IIc (Slightly Depressed Type)


name: [Stomach Macroscopic Classification] Type0-III (Superficial and Excavated Type)


name: [Stomach Macroscopic Classification] Type1 (Protruding Type)


name: [Stomach Macroscopic Classification] Type2 (Ulcerative and Localized Type)


name: [Stomach Macroscopic Classification] Type3 (Ulcerative and Infiltrative Type)


name: [Stomach Macroscopic Classification] Type4 (Diffusely Infiltrative Type)


name: [Stomach Macroscopic Classification] Type5 (Unclassified Type)


name: Post Other Endoscopic Treatment (Specify)


name: Post Pylorus Preserving Gastrectomy <PPG>


name: Post Pylorus-preserving Pancreaticoduodenectomy <PPPD>


name: Hemostasis of Varicose Vein (including Prevention)


name: [Stomach Major Histological Diagnosis] Muc


name: [Stomach Major Histological Diagnosis] n.a.


name: [Stomach Major Histological Diagnosis] Others


name: [Stomach Major Histological Diagnosis] Pap


name: [Stomach Major Histological Diagnosis] Por


name: [Stomach Major Histological Diagnosis] Sig


name: [Stomach Major Histological Diagnosis] Tub1


name: [Stomach Major Histological Diagnosis] Tub2


name: [Stomach Minor Histological Diagnosis] Muc


name: [Stomach Minor Histological Diagnosis] Others


name: [Stomach Minor Histological Diagnosis] Pap


name: [Stomach Minor Histological Diagnosis] Por


name: [Stomach Minor Histological Diagnosis] Sig


name: [Stomach Minor Histological Diagnosis] Tub1


name: [Stomach Minor Histological Diagnosis] Tub2


name: [Stomach Pathological Invasion Depth] Deeper than SM2


name: [Stomach Pathological Invasion Depth] n.a.


name: [Stomach Pathological Invasion Depth] SM1


name: [Stomach Pathological Macroscopic Classification] n.a.


name: [Stomach Pathological Macroscopic Classification] Type 0-I (Protruding Type)


name: [Stomach Pathological Macroscopic Classification] Type0-IIa (Superficial Elevated Type)


name: [Stomach Pathological Macroscopic Classification] Type0-IIb (Superficial Flat Type)


name: [Stomach Pathological Macroscopic Classification] Type0-IIc (Superficial Depressed Type)


name: [Stomach Pathological Macroscopic Classification] Type0-III (Excavated Type)


name: [Duodenum Macroscopic Classification] Excavated


name: [Duodenum Macroscopic Classification] non-Exposed Protruded Type


name: [Duodenum Macroscopic Classification] Other Type (Specify)


name: [Duodenum Macroscopic Classification] Protruded (Protruding)


name: [Duodenum Macroscopic Classification] Protruded-predominant Type


name: [Duodenum Macroscopic Classification] Type 0-I (Protruding Type)


name: [Duodenum Macroscopic Classification] Type0-IIa (Slightly Elevated Type)


name: [Duodenum Macroscopic Classification] Type0-IIb (Flat Type)


name: [Duodenum Macroscopic Classification] Type0-IIc (Slightly Depressed Type)


name: [Duodenum Macroscopic Classification] Type0-III (Superficial and Excavated Type)


name: [Duodenum Macroscopic Classification] Type1 (Protruding Type)


name: [Duodenum Macroscopic Classification] Type2 (Ulcerative and Localized Type)


name: [Duodenum Macroscopic Classification] Type3 (Ulcerative and Infiltrative Type)


name: [Duodenum Macroscopic Classification] Type4 (Diffusely Infiltrative Type)


name: [Duodenum Macroscopic Classification] Type5 (Unclassified Type)


name: [Duodenum Macroscopic Classification] Ulcerative type


name: [Duodenum Macroscopic Classification] Ulcerative-predominant Type


name: [Post Other Endoscopic Treatment] Recurrence


name: [Duodenum Major Histological Diagnosis] Muc


name: [Duodenum Major Histological Diagnosis] n.a.


name: [Duodenum Major Histological Diagnosis] Others


name: [Duodenum Major Histological Diagnosis] Pap


name: [Duodenum Major Histological Diagnosis] Por


name: [Duodenum Major Histological Diagnosis] Sig


name: [Duodenum Major Histological Diagnosis] Tub1


name: [Duodenum Major Histological Diagnosis] Tub2


name: [Duodenum Minor Histological Diagnosis] Muc


name: [Duodenum Minor Histological Diagnosis] Others


name: [Duodenum Minor Histological Diagnosis] Pap


name: [Duodenum Minor Histological Diagnosis] Por


name: [Duodenum Minor Histological Diagnosis] Sig


name: [Duodenum Minor Histological Diagnosis] Tub1


name: [Duodenum Minor Histological Diagnosis] Tub2


name: [Duodenum Pathological Invasion Depth] Deeper than SM2


name: [Duodenum Pathological Invasion Depth] M


name: [Duodenum Pathological Invasion Depth] n.a.


name: [Duodenum Pathological Invasion Depth] SM1


name: [Duodenum Pathological Macroscopic Classification] n.a.


name: [Duodenum Pathological Macroscopic Classification] Type 0-I (Protruding Type)


name: [Duodenum Pathological Macroscopic Classification] Type0-IIa (Superficial Elevated Type)


name: [Duodenum Pathological Macroscopic Classification] Type0-IIb (Superficial Flat Type)


name: [Duodenum Pathological Macroscopic Classification] Type0-IIc (Superficial Depressed Type)


name: [Duodenum Pathological Macroscopic Classification] Type0-III (Excavated Type)


name: [Colon Macroscopic Classification] Laterally Spreading Tumor - Granular <LST-G>


name: [Colon Macroscopic Classification] Laterally Spreading Tumor - Non-granular <LST-NG>


name: [Colon Macroscopic Classification] Remnant Recurrence


name: [Colon Macroscopic Classification] Type0-IIa (Superficial Elevated Type)


name: [Colon Macroscopic Classification] Type0-IIa+IIc (Superficial Elevated + Superficial Depressed Type)


name: [Colon Macroscopic Classification] Type0-IIb (Flat Type)


name: [Colon Macroscopic Classification] Type0-IIc (Superficial Depressed Type)


name: [Colon Macroscopic Classification] Type0-Ip (Pedunculated Type)


name: [Colon Macroscopic Classification] Type0-Ip+IIa (Pedunculated + Superficial Elevated Type)


name: [Colon Macroscopic Classification] Type0-Ip+IIc (Pedunculated + Superficial Depressed Type)


name: [Colon Macroscopic Classification] Type0-Is(p) (Semipedunculated Type)


name: [Colon Macroscopic Classification] Type0-Is(p)+IIa (Semipedunculated + Superficial Elevated Type)


name: [Colon Macroscopic Classification] Type0-Is(p)+IIc (Semipedunculated + Superficial Depressed Type)


name: [Colon Macroscopic Classification] Type1 (Protruding Type)


name: [Colon Macroscopic Classification] Type2 (Ulcerative and Localized Type)


name: [Colon Macroscopic Classification] Type3 (Ulcerative and Infiltrative Type)


name: [Colon Macroscopic Classification] Type4 (Diffusely Infiltrative Type)


name: [Colon Macroscopic Classification] Type5 (Unclassified Type)


name: [Endoscopic Invasion Depth Diagnosis of the Colorectal Cancer] M(Tis)


name: [Endoscopic Invasion Depth Diagnosis of the Colorectal Cancer] MP


name: [Endoscopic Invasion Depth Diagnosis of the Colorectal Cancer] S(+) A(+)


name: [Endoscopic Invasion Depth Diagnosis of the Colorectal Cancer] SM Mild (T1a)


name: [Endoscopic Invasion Depth Diagnosis of the Colorectal Cancer] SM Severe (T1b)


name: [Endoscopic Invasion Depth Diagnosis of the Colorectal Cancer] SS


name: [Narrow Band Imaging Diagnosis <NBI>] JNET Type1


name: [Narrow Band Imaging Diagnosis <NBI>] JNET Type2A


name: [Narrow Band Imaging Diagnosis <NBI>] JNET Type2B


name: [Narrow Band Imaging Diagnosis <NBI>] JNET Type3


name: [Narrow Band Imaging Diagnosis <NBI>] Undecidable


name: [Pit Pattern Diagnosis] II (Asteroid pit)


name: [Pit Pattern Diagnosis] IIIH (Fern leaf pattern pit)


name: [Pit Pattern Diagnosis] IIIL (Tubular or round pit that is larger than the normal pit)


name: [Pit Pattern Diagnosis] IIIS (Tubular or round pit that is smaller than the normal pit)


name: [Pit Pattern Diagnosis] IV (Dendritic or gyrus-like pit)


name: [Pit Pattern Diagnosis] IVH (Pinecone pattern pit)


name: [Pit Pattern Diagnosis] VI invasive (Irregular arrangement and size of IIIL,IIIS,IV type pit pattern)


name: [Pit Pattern Diagnosis] VI non-invasive (Irregular arrangement and size of IIIL,IIIS,IV type pit pattern)


name: [Pit Pattern Diagnosis] VN (Loss or decrease of pits with an amorphous structure)


name: [Familial Adenomatous Polyposis <FAP>] Dense type


name: [Familial Adenomatous Polyposis <FAP>] non Dense type


name: [Post Descending Colectomy] Anastomotic Recurrence - Yes


name: [Post Descending Colectomy] Anastomotic Stenosis - Yes


name: [Post Endoscopic Treatment] No Remnant Recurrence


name: [Post Endoscopic Treatment] Other (Specify)


name: [Post Endoscopic Treatment] Remnant Recurrence


name: [Post Hartmann's Operation] Anastomotic Recurrence - Yes


name: [Post Hartmann's Operation] Anastomotic Stenosis - Yes


name: [Post High Anterior Resection <HAR>] Anastomotic Recurrence - Yes


name: [Post High Anterior Resection <HAR>] Anastomotic Stenosis - Yes


name: [Post Ileocolic Resection] Anastomotic Recurrence - Yes


name: [Post Ileocolic Resection] Anastomotic Stenosis - Yes


name: [Post Left Hemicolectomy] Anastomotic Recurrence - Yes


name: [Post Left Hemicolectomy] Anastomotic Stenosis - Yes


name: [Post Local Excision (Surgery)] Anastomotic Recurrence - Yes


name: [Post Local Excision (Surgery)] Anastomotic Stenosis - Yes


name: [Post Low Anterior Resection <LAR>] Anastomotic Recurrence - Yes


name: [Post Low Anterior Resection <LAR>] Anastomotic Stenosis - Yes


name: [Post Miles'ope (abdominoperineal excision of rectum)] Anastomotic Recurrence - Yes


name: [Post Miles'ope (abdominoperineal excision of rectum)] Anastomotic Stenosis - Yes


name: [Post Right Hemicolectomy] Anastomotic Recurrence - Yes


name: [Post Right Hemicolectomy] Anastomotic Stenosis - Yes


name: [Post Sigmoid Colectomy] Anastomotic Recurrence - Yes


name: [Post Sigmoid Colectomy] Anastomotic Stenosis - Yes


name: [Post Surgery of Familial Adenomatous Polyposis <FAP>] Anastomotic Recurrence - Yes


name: [Post Surgery of Familial Adenomatous Polyposis <FAP>] Anastomotic Stenosis - Yes


name: [Post Total Colectomy] Anastomotic Recurrence - Yes


name: [Post Total Colectomy] Anastomotic Stenosis - Yes


name: [Post Transverse Colectomy] Anastomotic Recurrence - Yes


name: [Post Transverse Colectomy] Anastomotic Stenosis - Yes


name: [Serrated polyposis syndrome(SPS)] more than 2 (10mm or more)


name: [Serrated polyposis syndrome(SPS)] more than 20


name: [Post Local Excision (Surgery)] Anastomotic Recurrence - No


name: [Post Local Excision (Surgery)] Anastomotic Stenosis - No


name: [Post Ileocolic Resection] Anastomotic Recurrence - No


name: [Post Ileocolic Resection] Anastomotic Stenosis - No


name: [Post Right Hemicolectomy] Anastomotic Recurrence - No


name: [Post Right Hemicolectomy] Anastomotic Stenosis - No


name: [Post Transverse Colectomy] Anastomotic Recurrence - No


name: [Post Left Hemicolectomy] Anastomotic Recurrence - No


name: [Post Left Hemicolectomy] Anastomotic Stenosis - No


name: [Post Descending Colectomy] Anastomotic Recurrence - No


name: [Post Descending Colectomy] Anastomotic Stenosis - No


name: [Post Sigmoid Colectomy] Anastomotic Recurrence - No


name: [Post Sigmoid Colectomy] Anastomotic Stenosis - No


name: [Post High Anterior Resection <HAR>] Anastomotic Recurrence - No


name: [Post High Anterior Resection <HAR>] Anastomotic Stenosis - No


name: [Post Low Anterior Resection <LAR>] Anastomotic Recurrence - No


name: [Post Low Anterior Resection <LAR>] Anastomotic Stenosis - No


name: [Post Miles'ope (abdominoperineal excision of rectum)] Anastomotic Recurrence - No


name: [Post Miles'ope (abdominoperineal excision of rectum)] Anastomotic Stenosis - No


name: [Post Surgery of Familial Adenomatous Polyposis <FAP>] Anastomotic Recurrence - No


name: [Post Surgery of Familial Adenomatous Polyposis <FAP>] Anastomotic Stenosis - No


name: [Post Hartmann's Operation] Anastomotic Recurrence - No


name: [Post Hartmann's Operation] Anastomotic Stenosis - No


name: [Post Total Colectomy] Anastomotic Recurrence - No


name: [Post Total Colectomy] Anastomotic Stenosis - No


name: Endoscopic submucosal resection with ligation device <ESMR-L>


name: [Colon Major Histological Diagnosis] Hyper


name: [Colon Major Histological Diagnosis] Muc


name: [Colon Major Histological Diagnosis] n.a.


name: [Colon Major Histological Diagnosis] Others (Specify)


name: [Colon Major Histological Diagnosis] Pap


name: [Colon Major Histological Diagnosis] Por


name: [Colon Major Histological Diagnosis] SSA/P


name: [Colon Major Histological Diagnosis] TSA


name: [Colon Major Histological Diagnosis] Tub1


name: [Colon Major Histological Diagnosis] Tub2


name: [Colon Minor Histological Diagnosis (For Mixed Type)] Hyper


name: [Colon Minor Histological Diagnosis (For Mixed Type)] Muc


name: [Colon Minor Histological Diagnosis (For Mixed Type)] n.a.


name: [Colon Minor Histological Diagnosis (For Mixed Type)] Others (Specify)


name: [Colon Minor Histological Diagnosis (For Mixed Type)] Pap


name: [Colon Minor Histological Diagnosis (For Mixed Type)] Por


name: [Colon Minor Histological Diagnosis (For Mixed Type)] Sig


name: [Colon Minor Histological Diagnosis (For Mixed Type)] SSA/P


name: [Colon Minor Histological Diagnosis (For Mixed Type)] TSA


name: [Colon Minor Histological Diagnosis (For Mixed Type)] Tub1


name: [Colon Minor Histological Diagnosis (For Mixed Type)] Tub2


name: [Colon Pathological Invasion Depth] M(Tis)


name: [Colon Pathological Invasion Depth] SM(T1a)


name: [Colon Pathological Invasion Depth] SM(T1b)


name: [Other] Associated with Systemic Diseases


name: [Post Endoscopic Treatment Evaluation] Post Endoscopic Treatment


name: [Post-treatment evaluation] After No Treatment Follow-up


name: [Post-treatment evaluation] Post Chemotherapy


name: [Post-treatment evaluation] Post Conformal Radiation Treatment


name: [Post-treatment evaluation] Post Radiotherapy


name: [Major Papilla Macroscopic Classification] Cystic Type


name: [Major Papilla Macroscopic Classification] Ductectatic Type


name: [Major Papilla Macroscopic Classification] Masked Type


name: [Major Papilla Macroscopic Classification] Mixed Type


name: [Major Papilla Macroscopic Classification] Nodular Type


name: [Major Papilla Macroscopic Classification] Unclassifiable Type


name: [Post Endoscopic Treatment] Endoscopic Papillary Balloon Dilation <EPBD>


name: [Post Endoscopic Treatment] Pancreatic Sphincterotomy


name: [Post Endoscopic Treatment] Papilla Sphincterotomy


name: [Enlargement] Post Excretion of Bile Duct Gallstones


name: [Major Papilla Ampulla (Fish mouth)] By Intraductal Papillary Mucinous Neoplasm <IPMN>


name: [Major Papilla Ampulla (Fish mouth)] By Intraductal Papillary Neoplasm <IPNB>


name: [Post Endoscopic Treatment] Ablation (Argon Plasma Coagulation)


name: [Post Endoscopic Treatment] Endoscopic Papillectomy


name: [Post Major Papilla Surgery] Post Pancreaticoduodenectomy


name: [Post Major Papilla Surgery] Post Papilloplasty


name: [Radiography Unsuccessful] Accession Unsuccessful


name: [Radiography Unsuccessful] Cannulation Unsuccessful


name: [Radiography Unsuccessful] Other (Specify)


name: Percutaneous Transhepatic Cholangioscopy <PTCS>


name: Drainage Stenting for Major Papillary Lesion [EBD]


name: Drainage Stenting for Major Papillary Lesion [Other]


name: Drainage Stenting for Major Papillary Lesion [PTBD]


name: Drainage Stenting for Major Papillary Lesion [PTGBA]


name: Drainage Stenting for Major Papillary Lesion [PTGBD]


name: Drainage Stenting for Major Papillary Lesion [Stent Removal]


name: Endoscopic Papillary Balloon Dilation <EPBD>


name: Endoscopic Papillary Large Balloon Dilation <EPLBD>


name: Endoscopic Sphincterotomy <EST> for Major Papillary Lesion


name: [Filling Defect (Other than stones )] Air Bubble


name: [Filling Defect (Other than stones )] Biliary Sludge


name: [Filling Defect (Other than stones )] Mass


name: [Filling Defect (Other than stones )] T-tube


name: [History of Surgery] Cholecystenterostomy


name: [History of Surgery] Choledochoduodenostomy


name: [History of Surgery] Choledochojejunostomy


name: [History of Surgery] Liver Transplantation


name: [Low Cystic Duct Bifurcation] Distance from Major Papilla 2 cm or less


name: [Low Cystic Duct Bifurcation] Distance from Major Papilla 2 cm or more


name: [Number of Stones] Five or Less (Specify the number of pieces)


name: [Choledochal Cyst] Alonso-Lej Classification Type I


name: [Choledochal Cyst] Alonso-Lej Classification Type II


name: [Choledochal Cyst] Choledochocele Alonso-Lej Classification Type III


name: [Choledochal Cyst] Todani Classification Type I


name: [Choledochal Cyst] Todani Classification Type II


name: [Choledochal Cyst] Todani Classification Type III


name: [Choledochal Cyst] Todani Classification Type IV


name: [Post Bile Tract Surgery] Post Cholecystectomy


name: [Post Bile Tract Surgery] Post Choledochojejunostomy


name: [Post Bile Tract Surgery] Post Distal Pancreatectomy


name: [Post Bile Tract Surgery] Post Left Hepatic Lobectomy


name: [Post Bile Tract Surgery] Post Pancreatoduodenectomy


name: [Post Bile Tract Surgery] Post Right Hepatic Lobectomy


name: Normal Biliary Tract Image Post Cholecystectomy


name: [Biliay Tract Macroscopic Classification] Filling Type


name: [Biliay Tract Macroscopic Classification] Flat-expanding Type


name: [Biliay Tract Macroscopic Classification] Flat-infiltrating Type


name: [Biliay Tract Macroscopic Classification] Massive Type


name: [Biliay Tract Macroscopic Classification] Nodular-expanding Type


name: [Biliay Tract Macroscopic Classification] Papillary-expanding Type


name: [Biliay Tract Macroscopic Classification] Papillary-infiltrating Type


name: [Biliay Tract Macroscopic Classification] Type 0-I (Protruding Type)


name: [Biliay Tract Macroscopic Classification] Type0-II (Superficial Type)


name: [Biliay Tract Macroscopic Classification] Type0-IIa (Slightly Elevated Type)


name: [Biliay Tract Macroscopic Classification] Type0-IIb (Flat Type)


name: [Biliay Tract Macroscopic Classification] Type0-IIc (Slightly Depressed Type)


name: [Biliay Tract Macroscopic Classification] Type0-III (Superficial and Excavated Type)


name: [Biliay Tract Macroscopic Classification] Type0-Ip (Pedunculated Type)


name: [Biliay Tract Macroscopic Classification] Type0-Is (Sessile (Broad Based) Type)


name: Percutaneous Transhepatic Cholangio Drainage <PTCD>


name: Ultrasonic Size - Major Axis (mm) (Specify)